Beta Drugs Limited (NSEI:BETA) agreed to acquire Adley Lab Ltd from a group of shareholders for INR 45.04 million on May 29, 2019. Beta Drugs Limited entered into share purchase agreement to acquire Adley Lab Ltd from group of shareholders on June 28, 2019. Beta Drugs Limited (NSEI:BETA) will acquire 1.75 million shares. The total value of the consideration payable is INR 45 million which is discharged by issue of 0.31 million Equity Shares preferential basis and the remaining by normal banking channels. The transaction is approved by the acquirer's shareholders on June 28, 2019. Beta Drugs Limited (NSEI:BETA) acquired Adley Lab Ltd from group of shareholders on October 25, 2019.